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ROSresumably an undesirable event in cancer prevention process, thus biochemical
comprehension and molecular deﬁnition of this process could have important clinical implications. In the
present study, we examined the cytophysiological conversion of cell death mode by benzyl isothiocyanate
(BITC) in human cervical cancer HeLa cells. The detailed studies using ﬂow cytometric and morphological
analyses demonstrated that the cells treated with appropriate concentration (25 μM) of BITC showed
apoptotic feature, such as chromatin condensation, DNA fragmentation, and preserved plasma membrane
integrity, whereas these features were disappeared by treatment with higher concentration (100 μM). The
treatment with 2-deoxyglucose, an inhibitor of ATP synthesis, drastically increased in the ratio of necrotic
dead cells, while it inﬂuences little that of apoptotic cells. Moreover, an analysis using the mitochondrial
DNA-deﬁcient HeLa cells demonstrated that the ρ° cells were more susceptible to the BITC-induced necrosis-
like cell death compared to the wild-type (ρ+) cells, whereas the ROS productionwas signiﬁcantly inhibited in
the ρ° cells. It is likely that the BITC-induced ROS is derived from mitochondrial respiratory chain and ruled
out the contribution to the mechanism of cell death mode switching. In addition, the BITC treatment resulted
in a more rapid depletion of ATP in the ρ° cells than in the ρ+ cells. Furthermore, a caspase inhibitor, Z-VAD-
fmk counteracted not only apoptosis, but also necrosis-like cell death induced by BITC, suggesting that
increment in this cell death pattern might be due to the interruption of events downstream of a caspase-
dependent pathway. The obtained data suggested that the decline in the intracellular ATP level plays an
important role in tuning the mode of cell death by BITC.
© 2008 Elsevier B.V. All rights reserved.1. Introduction
A number of studies support the idea that certain food phyto-
chemicals protect against cancer. An important group of food
compounds that have a cancer chemopreventive property is organo-
sulfur compounds including isothiocyanates (ITCs). ITCs are com-
pounds that occur as glucosinolates in a variety of cruciferous
vegetables such as Brussica species. Naturally occurring ITC com-
pounds are effective preventive agents against chemical carcinogen-
esis in the lung, the esophagus, the mammary gland, the liver, the
small intestine, the colon, and the bladder [1]. Epidemiological studiesSH, glutathione; ROS, reactive
lucose; PI, propidium iodide;
te dehydrogenase; ETP, etopo-
idase; TR, thioredoxin; GST,
ase catalytic subunit; GAPDH,
aldo-keto reductase 1C; TR,
mura).
ll rights reserved.also indicate a signiﬁcant correlation between the dietary intake of
ITC-containing foods and the reduced risk for several cancers [2–4].
Mechanistically, ITCs are capable of inhibiting both the formation and
development of a cancer cell through multiple pathways; i.e., the
inhibition of carcinogen-activating cytochrome P450 monooxy-
genases, induction of carcinogen-detoxifying enzymes, induction of
apoptosis, and inhibition of the cell cycle progression [5]. We recently
clariﬁed the molecular mechanism underlying the relationship
between cell cycle arrest and apoptosis induced by benzyl ITC (BITC)
[6]. Additionally, we demonstrated that antioxidant mechanisms also
potentially contribute to a BITC-mediated chemoprevention against
inﬂammation-related carcinogenesis [7].
In contrast, there is abundant evidence that ITCs induce cellular
stress themselves [8]. The concentration of ITCs required for cellular
stress induction exceeds or, at least some parts, overlaps those needed
for the enhancement of the cellular antioxidant protein expression or
apoptosis induction. The unfavorable effect of higher concentrations
of ITCs has been observed; e.g., the treatment with an excessive
concentration of BITC resulted in severe cytotoxicity with caspase-3
inactivation and no DNA ladder formation [6,9]. Some in vivo
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ITCs. For instance, both BITC and phenethyl ITC (PEITC) promote
urinary bladder carcinogenesis in rats treatedwith diethylnitrosamine
and N-butyl-N-(4-hydroxybutyl)nitrosamine. Since the employed
dose was higher than that required for chemoprevention [10], the
promotional effect of ITCs could be dependent on their concentration.
Taken together, it is suggested that accidental cell death induced by
higher concentrations of BITC might be involved in its ability to
promote carcinogenesis [11].
The death of a cell can be deﬁned as an irreversible loss of plasma
membrane integrity [12]. Historically, three types of cell death have
been distinguished in mammalian cells by morphological criteria.
‘Apoptosis’ is accompanied by rounding-up of the cell, retraction of
pseudopodes, reduction of cellular volume (pyknosis), condensation
of the chromatin, fragmentation of the nucleus (keryorhexis), little or
no ultrastructural modiﬁcation of cytoplasmic organelles, plasma
membrane blebbing, and maintenance of an intact plasma membrane
until late stages of the process. ‘Autophagic cell death’ is characterized
by a massive accumulation of two-membrane autophagic vacuoles in
the cytoplasm. ‘Necrosis’ is usually considered as a type of cell death
with no signs of apoptosis or of autophagy, which is a negative
deﬁnition [13]. The distinction between cell death type is important,
particularly because necrosis is often associatedwith unwarranted cell
loss in human pathologies [14–16] and can lead to local inﬂammation,
presumably through the liberation of factors from dead cells that alert
the innate immune system [14,17,18]. Although recent some
researches suggest a ‘programmed’ necrotic cell death for some
reasons [19–21] it's still obscure that molecular mechanism of
chemopreventive ITC induced necrotic cell death.
In the present study, we examined the switchingmechanism of the
cell demise mode from apoptosis to necrosis-like cell death using
different concentrations of BITC. We also observed that BITC-induced
ROS production is closely correlated with modiﬁcation of mitochon-
drial respiration chain but ruled out in the mechanism of cell death
mode alteration. This is the ﬁrst report that changing the mode of cell
death produced by BITC depends on its concentration and intracellular
ATP level.
2. Materials and methods
2.1. Chemicals
BITC and Triton X-100™ were obtained from Nacalai Tesque, Inc.,
Kyoto, Japan. Trypan blue and 2-deoxyglucose (2-DG) were purchased
from Sigma, St. Louis, MO. Propidium iodide (PI) and 2′,7′-dichloro-
ﬂuorescin diacetate (H2DCF-DA) were obtained from Molecular
Probes, Inc., Eugene, OR. Z-VAD-fmk was obtained from Peptide
Institute (Osaka, Japan). All other chemicals were purchased from
Wako Pure Chemical Industries, Osaka, Japan.
2.2. Cell culture and preparation of ρ cells
The human cervix adenocarcinoma HeLa cells (provided by Dr.
Hideki Shibata of Nagoya University) were maintained in DMEM
(Nissui, Tokyo, Japan) supplemented with 10% FBS, 50 units/ml
penicillin, and 50 μg/ml streptomycin, and grown in an atmosphere of
95% air and 5% CO2 at 37 °C. The HeLa ρ° cells depleted of mtDNA
were generated from the HeLa wild-type (ρ+) cells by long-term
exposure to ethidium bromide [22]. Brieﬂy, HeLa cells were cultured
in 10% FBS containing DMEM supplemented with 0.05 μg/ml
ethidium bromide, 0.05 mg/ml uridine, 0.11 mg/ml sodium pyruvate,
and 3.5 mg/ml glucose for more than 1 month. The surviving HeLa ρ°
cells that formed colonies in the culture dish were harvested and
tested as described below. The depletion of mitochondrial DNA was
conﬁrmed by PCR using the following primer: 5′-GTAGGAGAGTGA-
TATTTGATCAGG-3′, and 5′-CCATCTGCCTACGACAAACAGACC-3′.2.3. Assay for cell viability
The MTT assay and Trypan blue dye exclusion assay were carried
out for the quantitative analysis of cell viability. After culturing with
BITC at 37 °C for 18 h, 10 μl of an MTT solutionwas added to each well,
and the ﬂuorescence was measured with excitation at 560 nm and
emission at 590 nm according to the manufacturer's instructions after
incubation at 37 °C for 2–3 h in a humidiﬁed CO2 incubator. The
obtained values were compared with each of the controls incubated
with vehicle only. For the Trypan blue dye exclusion assay, the cells
cultured with BITC at 37 °C for 24 h were harvested, collected by
centrifugation, and resuspended in PBS. The cell suspensions were
mixed with 0.4% Trypan blue stain. The total cells and viable cells (cell
that excluded blue dye) were counted using a hemocytometer under a
light microscope.
2.4. Detection of nuclear fragmentation
For the DNA fragmentation analysis, HeLa cells (5×105 cells) were
incubated in culture medium in the presence or absence of BITC or
etoposide (ETP). Both the attached and ﬂoating cells were pelleted by
centrifugation, and DNA was isolated from the cell pellets as
previously described [6]. The DNA was then subjected to electrophor-
esis in 2% agarose gels, stained with ethidium bromide, and imaged
with a FluorImager (Molecular Dynamics, Tokyo, Japan). Apoptotic cell
death was also evaluated by ﬂuorescence microscopy. After incubated
with BITC, HeLa cells staining with Hoechst 33342 and PI were
observed under a confocal ﬂuorescence microscope (LSM 510 META,
Carl Zeiss, Inc., Thornwood, NY).
2.5. Flow cytometric analysis
For the analysis of apoptosis/necrosis, we used an annexin V-FITC
Apoptosis Detection kit (Medical and Biological Laboratories Co., Ltd.,
Nagoya, Japan) according to the protocol by the manufacturer. Both
the attached and ﬂoating cells were stained with annexin V-FITC and
PI. Flow cytometric analyses were performed using BD FACSCanto II
(BD Bioscience, San Jose, CA). The intracellular oxidative products
were detected by H2DCF-DA as an intracellular ﬂuorescence probe.
Brieﬂy, the cells were treated with H2DCF-DA (50 μM) for 30 min at
37 °C. After washing twice with PBS, the BITC was added to the
complete medium and incubated for another 2 h. Then, ﬂow
cytometric analysis was performed to detect DCF formed by the
reaction of H2DCF with the intracellular oxidative products.
2.6. Reverse transcription-polymerase chain reaction (RT-PCR)
Total RNA was isolated with Isogen reagent (Nippon Gene, Tokyo,
Japan) and spectrophotometrically quantiﬁed. The RT reaction was
performed with 1 μg of total RNA using the SuperScript™ First-Strand
Synthesis System for RT-PCR (Invitrogen, Carlsbad, CA) according to
the manufacturer's protocol. PCR was carried out using TaKaRa Ex Taq
(TaKaRa bio, Inc., Tokyo, Japan). The following primers were used:
SOD1-(F) 5′-CGAGCAGAAGGAAAGTAATGG-3′ and (R) 5′-AAGTCGTTT-
GGCTTGTGGTGT-3′ and SOD2-(F) 5′-CCTGGAACCTCACATCAACG-3′ and
(R) 5′-GAAGGTAGTAAGCGTGCTCC-3′ and glutathione peroxidase 1
(GPx1)-(F) 5′-AGTCGGTGTATGCCTTCTCG-3′ and (R) 5′-GAATCTCTT-
CGTTCTTGGCG-3′ and GPx4-(F) 5′-GCACATGGTTAACCTGGACA-3′ and
(R) 5′-AAATAGTGGGGCAGGTCCTT-3′ and thioredoxin (TR)-(F) 5′-TCG-
CTTTGGAGTGCGCTGGA-3′ and (R) 5′-GGCCACAAGCACCATATTCCAA-3′
and glutathione-S-transferase P1 (GSTP1)-(F) 5′-CTCACTCAAAG-
CCTCCTGCCTAT-3′ and (R) 5′-CAGGATGGTATTGGACTGGTACAG-3′ and
glutamate-cysteine ligase catalytic subunit (GCLC)-(F) 5′-TTGATTAA-
GGCTTTCTTTGGTAGG-3′ and (R) 5′-TTTCAATAAATCAGGTCCCAGG-3′
and β-actin-(F) 5′-GTCACCCACACTGTGCCCATCTA-3′ and (R) 5′-
GCAATGCCAGGGTACATGGTGGT-3′ and glyceraldehyde-3-phosphate
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(R) 5′-CACAGTCTTCTGAGTGGCAGTGAT-3.′
2.7. Measurement of intracellular ATP level
Intracellular ATP was measured using an ATP Determination Kit
(Molecular Probes) according to the manufacturer's protocol. Brieﬂy,
the attached cells were harvested with 100 μl of 100 mM Tris–HCl and
4 mM EDTA, boiled for 2 min, and centrifuged at 4000 rpm for 1 min.
After mixing 10 μl from each of the supernatants or the 0–25 μM ATP
standard solutionwith 90 μl of the ATP standard reaction solution, the
emitted light was measured. Aliquots from each sample were used for
measuring protein concentration using the BCA protein assay kit
(Pierce). The blank value (no ATP) was subtracted from each sample's
raw data, and ﬁnally the ATP concentrations were calculated from the
linear part of a standard curve and expressed as the relative ATP
content or nmol per mg protein.
2.8. Caspase activity determination
Caspase-3-like activity was monitored by the cleavage of Ac-Asp-
Glu-Val-Asp-p-nitroanilide (DEVD-pNA) according to the protocolFig. 1. Dose-dependent effect of BITC on the apoptosis and necrosis induction. HeLa cells were
reconstitution. The cell population of annexinV (+)/PI (−) (□) and annexin V (+)/PI (+) (■) in ea
were quantiﬁed using BD FACSDiva software. Data are means of three experiments. B and C s
performed quantitative analyses byBD FACSDiva software for the cells treatedwith 25 (●), or 1
test and expressed as: ⁎, versus counterpart of the cells treatedwith 25mMBITC, PMBITC, P b
BITC or etoposide (ETP; lane 7) at the indicated concentration for 18 h.outlined by the manufacturer in a caspase-3 Colorimetric Protease
Assay Kit (Medical and Biological Laboratories, Nagoya, Japan). The
caspase-3-like activity was determined in the cytosolic extracts of
HeLa cells that had been preincubated with or without 12.5 mM 2DG
for 12.5 h followed by treatment with 25 μM BITC for 9 h.
2.9. Statistical analyses
When applicable, the mean±standard deviation (SD) values are
shown. Signiﬁcant difference among treatments was examined using
Student's t test (two sided), which assumed unequal variance.
3. Results
3.1. BITC-induced cell death with apoptotic and necrotic features in
HeLa cells
In our and other previous studies, BITC showed a cytotoxic effect in
several cultured cell lines [6,9,23–32]. Since these cell lines have
individually different cellular features associated with cell death
regulatory factors, such as the intracellular redox status, MAP kinase
activities, and cell cycle regulation-related proteins, the 50% inhibitorytreatedwith BITC at indicated concentration. (A) Effect of BITC on the plasmamembrane
ch quarter area ofﬂowcytometric analysis (representative data are shown in Fig. S1Da–e)
ummarized the effect of BITC on plasma membrane disruption (B) and cell swelling (C),
00 (■) BITC for indicated times. Statistical signiﬁcancewas determined by the Student's t
0.05. (D) DNA fragmentation in the BITC-treatedHeLa cells. The cellswere incubatedwith
Fig. 2. Involvement of intracellular ATP level in BITC-induced apoptosis and necrosis. (A)
Time-dependent effect of BITC on the intracellular ATP level and necrosis in the
attached HeLa cells. Values are mean±SD (n=3). No error bar means standard deviation
for the experiments was within 5%. Statistical signiﬁcance was determined by the
Student's t test and is expressed as: ⁎, versus control (0 h) treated only with DMSO,
Pb0.05. (B) Effect of an ATP synthesis inhibitor on the BITC-induced apoptosis and
necrosis. The cells pretreated with (open bars) or without (closed bars) 2-deoxyglucose
(2-DG) for 12.5 h were exposed to BITC at the indicated concentration for 9 h. Annexin
V/PI analysis were performed to identify the apoptotic (annexin V (+)/PI (−)) and
necrotic (annexin V (−)/PI (+)) cell death. (C) Effect of an ATP synthesis inhibitor on the
BITC-induced caspase-3 activation. Statistical signiﬁcance was determined by the
Student's t test and expressed as: a, versus BITC 0 μM group, Pb0.05, b, versus control
(without 2-DG) group with the same BITC concentration, Pb0.05.
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we used the human cervix adenocarcinoma HeLa cells widely used in
various investigations of cancer biology. First, we monitored the
cytotoxic activity of BITC in the HeLa cells using the modiﬁed MTT
assay and Trypan blue exclusion assay. When HeLa cells were
incubated with BITC, the viability was inhibited in a concentration-
dependent manner up to 100 μMwith an IC50 value of 42 μM (Fig. S1A
in the supplemental data available with this article online). The
Trypan blue exclusion assay also showed that the ratio of dead cells
dose-dependently increased (Fig. S1B). Furthermore, the loss of cell
membrane integrity was also measured by release of lactate
dehydrogenase (LDH) into the cell culture medium (Fig. S1C).
Although LDH release was observed with a time- and dose-
dependency up to 25 μM, no further increase was detected when
the cells were treatedwithmore than 25 μMBITC, whichmight be due
to the direct interference of LDH activity by BITC. We next performed
an annexin V/PI analysis to examine themembrane reconstitution and
permeabilization associated with BITC-induced cell death (Fig. 1A–C,
Fig. S1D). As shown in Fig. 1A, the treatment with 25 μM BITC for 3 h
resulted in a signiﬁcant increase in the annexin (+)/PI (−) and annexin
(+)/PI (+) populations (2.6-fold increase compared with control). The
change in these populations [annexin (+)] is time-dependent (Fig. 1A).
However, a greater amount of the annexin V (+)/PI (+) population was
induced by 100 μM BITC although the annexin V (+)/PI (−) one was
slightly induced (Fig. 1A). Besides, 100 μM BITC induced a rapid and
signiﬁcant membrane permeabilization, evaluated by the PI uptake,
when compared to treatment with 25 μM BITC (Fig. 1B). Furthermore,
the exposure of HeLa cells to 100 μM BITC resulted in a rapid cell
swelling with a peak at 1 h accompanied by a 1.5-fold cell size change
(Fig. 1C). Interestingly, we observed that the swollen cells still
remained their membrane integrity after the 1 h treatment with
100 μM BITC, suggesting severe cell swelling occurred prior to the
membrane disruption (Fig. S1D). In contrast, although 25 μM BITC
induced a weak cell swelling with a peak at 3 h (1.19-fold increase), it
coincided with the cell membrane disruption (Fig. 1B and C). These
morphological distinctions between the 25 and 100 μM BITC-induced
cell deaths suggest that obviously different cell death forms were
dose-dependently induced by BITC.
To obtain further evidence, the membrane disruption and nuclear
fragmentation were investigated using a ﬂuorescence dye, PI and
membrane permeable Hoechst 33342. As a result, although treatment
with 25 μM BITC for 2 h showed little effect on the membrane
disruption (stained less than 4%), many of the cells were stained by PI
after treatment with 100 μM BITC (Fig. S1E). Additionally, after
treatment with 25 μM BITC for 20 h, we observed the nuclear
chromatin condensed cells (9 of 53 cells in Fig. S1E), some of which
still have an intact cell membrane (6 of 9 cells in Fig. S1E).
Furthermore, treatment of the cells with 25 μM BITC resulted in a
signiﬁcant DNA fragmentation (Fig. 1D). Interestingly, when the cells
were treated with 50 μMBITC, DNA fragmentationwas not detected in
spite of the severe cytotoxicity, while the treatment of an excessive
concentration of etoposide (ETP, 500 μM) resulted in the DNA
fragmentation. These results showed that 100 μM BITC induces cell
death with neither a DNA fragmentation nor early apoptotic feature.
Our previous report demonstrated that caspase-3 and -9 were
activated by BITC at lower concentrations, while their activities were
reduced at the higher BITC concentration in RL34 cells [9]. Taken
together, we further conﬁrmed that BITC is able to regulate cell death
mode dependent on its concentration.
3.2. Involvement of intracellular ATP level to the determination of
BITC-induced cell death form
It is widely accepted that the intracellular ATP level is one of the
important factors to decide the cell death form when the cells were
exposed to a lethal stimulation [10,11,33]. Therefore, we comparedbetween the intracellularATP level andnecrotic cell ratio in BITC-treated
attached HeLa cells. As shown in Fig. 2A, the treatment with 50 μM of
BITC for 3 h signiﬁcantly reduced theATP level to 55% of the control level
coincided with 25% of the necrotic-featured dead cells. These results
suggested that depletion of ATP might be due to not only leak by
enhancement of membrane permeability but also inhibition of ATP
synthesis. Next, to examine the involvementof the intracellularATP level
on the switching of apoptosis/necrosis, HeLa cells were pretreated with
an ATP synthesis inhibitor, 2-deoxyglucose (2DG). Treatment with
12.5mM2DG resulted in anATPdepletion to 50% of the control level and
a slight cytotoxicity in HeLa cells (Fig. S2). As shown in Fig. 2B, the 2DG
pretreatment enhanced the susceptibility to both apoptosis and necrotic
cell death induced by BITC. Particularly, a higher ratio of necrotic-
featured cells was detected in the ATP-depleted cells treatedwith 25 μM
BITC. Consistent with this, caspase-3 activity was signiﬁcantly reduced
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the intracellular ATP level by BITC plays an important role in the
determination of the mode of cell death.
3.3. Effect of BITC on intracellular ROS production and cytotoxicity in
HeLa ρ° cells
The mitochondrial DNA-deﬁcient ρ° cell is widely used in studies
of the mitochondrial function, respiration, and mitochondria-derived
ROS. Therefore, we prepared HeLa ρ° cells (Fig. 3A) to investigate the
involvement of mitochondrial function alteration in the BITC-induced
change of cell death mode. As shown in Fig. 3B, the intracellular ROS
level in the HeLa ρ° cells was signiﬁcantly lower than in the wild-type
(ρ+) cells under the normal culture conditions. Moreover, BITC-
induced enhancement of the ROS level was signiﬁcantly suppressed
in the ρ° cells, although the inhibitory effect on the 50 μM BITC-
induced ROS productionwas also partly suppressed. In the meantime,
we observed that the ROS production induced by rotenone, a
mitochondrial respiration inhibitor, was completely abolished in the
ρ° cells whose mitochondrial membrane voltage was dysregulated
(Fig. S3). In addition, no signiﬁcant differences of various antioxidant
enzyme expressions between in the ρ+ and ρ° cells were observed (Fig.
3C). Furthermore, BITC failed to induce the antioxidant enzyme
expression including aldo–keto reductase 1C1/2 (AKR1C1/2), thior-
edoxin (TR), and GSTP1 in HeLa ρ+ cells (Fig. S4). These results
indicated that the BITC-induced ROS mainly originated from mito-
chondrial respiratory chain but not from the alteration of antioxidantFig. 3. Effect of BITC on ROS production in HeLa ρ cells. (A) The depletion of
mitochondrial DNA in HeLa ρ° cells. (B) Effect of BITC on the intracellular ROS
production in HeLa ρ cells. The wild-type HeLa ρ+ (closed bars) and mitochondrial DNA-
deﬁcient ρ° (open bars) cells were incubated with H2DCF-DA (50 μM) for 30 min and
then stimulated by BITC. Values are mean±SD (n=3). Statistical signiﬁcance was
determined by the Student's t test and expressed as: ⁎, versus the ρ+ cells groupwith the
same BITC concentration, Pb0.05. (C) mRNA expression proﬁle of antioxidant enzyme
genes in the ρ+ and ρ° cells were analyzed by RT-PCR.
Fig. 4. Effect of BITC on cytotoxicity in HeLa ρ cells. (A, B) Apoptosis and necrosis
induction by BITC in HeLa ρ cells. The HeLa ρ+ (closed bars) and ρ° (open bars) were
treated with BITC at the indicated concentration for 9.5 h. Statistical signiﬁcance was
determined by the Student's t test and expressed as: ⁎, versus the ρ+ cells groupwith the
same BITC concentration, Pb0.05. (C) DNA fragmentation in the BITC-treated HeLa ρ
cells. The HeLa ρ cells were incubated with BITC at the indicated concentration for 18 h.defense system, consistent with our reports that BITC can directly
modify the mitochondrial function [9,34].
Hence, we examined the effect of mitochondria deﬁciency on the
BITC-induced apoptosis and necrosis in the mitochondria DNA-
deﬁcient ρ° cells. As shown in Fig. 4A, the ratio of apoptotic cell
death induced by BITC in the ρ+ cells increased in a dose-dependent
manner up to 50 μM. Conversely, apoptotic cell death in the ρ° cells
were transiently increased with the peak of 23% apoptosis at 25 μM. In
the ρ° cells, treatment with 50 μM BITC resulted in reduction of the
apoptotic cell ratio and an increase in the cells with features of
necrosis (Fig. 4B). Also, the BITC-induced DNA fragmentation was
dose-dependently detected in the HeLa ρ+ cells, while a smaller
amount of fragmented DNA was observed in the 25 μM BITC-treated
HeLa ρ° cells (Fig. 4C) despite the ﬂow cytometry data that the annexin
Fig. 5. Effect of cycloheximide on cytotoxicity in HeLa ρ cells. (A, B) Apoptosis and
necrosis induction by cycloheximide (CHX) in HeLa ρ cells. The HeLa ρ+ (closed bars) and
ρ° (open bars) were treatedwith CHX at the indicated concentration for 9.5 h. Values are
mean±SD (n=3). Statistical signiﬁcance was determined by the Student's t test and
expressed as: ⁎, versus the ρ+ cells group with the same CHX concentration, Pb0.05.
Fig. 7. Inhibitory effect of caspase inhibitor on the BITC-induced apoptosis and necrosis
in HeLa ρ cells. The HeLa ρ+ and ρ° cells were treated with BITC for 9 h in the presence or
absence of the caspase inhibitor, Z-VAD-fmk. The maximum SD for the duplicated
experiments was 5% (n=3). a, signiﬁcantly different in apoptosis from each (ρ+ or ρ°)
control (0 μM BITC and Z-VAD-fmk), Pb0.05; b, signiﬁcantly different in necrosis from
each (ρ+ or ρ°) control (0 μM BITC and Z-VAD-fmk), Pb0.05; c, signiﬁcantly different in
total cell death (apoptosis + necrosis) from each (ρ+ or ρ°) control (0 μMBITC and Z-VAD-
fmk), Pb0.05.
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these cells (Fig. 4A). These contradictory observations might be due to
the fact that the DNA fragmentation is downstream of the apoptosis
process compared to phosphatidylserine outermembrane exposure or
that the concentration of BITC at 25 μM is nearly a threshold of tuning
the mode between apoptosis and necrosis-like cells.
In any case, signiﬁcant apoptosis/necrosis switching in the ρ° cells
might be selective to BITC, because cycloheximide (CHX), an anti-
cancer antibiotic inhibiting protein synthesis, exhibited a more potent
cytotoxic effect on the ρ+ cells than the ρ° cells, and apoptosis/necrosis
switching was not observed (Fig. 5A and B).Fig. 6. Effect of BITC on intracellular ATP level in HeLa ρ cells. The HeLa ρ+ (closed bars)
and ρ° (open bars) were treated with or without 25 μM BITC for the indicated times.
Values are mean±SD (n=3). Statistical signiﬁcance was determined by the Student's t
test and expressed as: ⁎, versus the ρ+ cells group with the same BITC concentration,
Pb0.05.3.4. Effect of BITC on intracellular ATP level in HeLa ρ° cells
To further explore the regulating mechanism of BITC-induced cell
death mode, we investigated the intracellular ATP level using the ρ°
cells. As shown in Fig. 6, the ATP level in the ρ+ cells was increased by
25 μM BITC up to 3 h, and sustained at the basal level 24 h after the
treatment. Conversely, the ATP level in the ρ° cells was signiﬁcantly
decreased 3 h after the BITC treatment, and continuously declined up
to 24 h. Thus, BITC might affect energy production system more
severely in the ρ° cells than in the ρ+ cells. Most of the energy
production in the ρ° cells depends on the glycolytic system due to the
deﬁciency of mitochondrial electron transport chain. The GAPDH
activities, one of the key enzymes for glycolytic system and it has been
reported that BITC is able to inactivate GAPDH in vitro by modulating
the cysteine residue at an active site center, slightly, but signiﬁcantly,
decreased in a BITC dose-dependent manner in the both of ρ° and ρ+
cells (Fig. S5). Although these partial inhibitory effects may be
insufﬁcient to explain the rapid ATP decline, BITC is very likely to
modify the total activity of glycolytic system.
3.5. Involvement of caspase cascade to the apoptosis/necrosis switch by
BITC
Our previous report showed that BITC activates caspase-9 and -3
during the apoptosis induction [9]. Here we examined the effect of
caspase inhibitor on the BITC-induced cell death in the ρ° cells.
Interestingly, Z-VAD-fmk, a caspase inhibitor, was capable of rescuing
the cells not only from apoptosis in the ρ+ cells, but also from necrosis-
like death in the ρ° cells regardless of the ATP deprivation (Fig. 7).
These results suggest that necrotic-featured cell death induced by
BITC is placed downstream of the caspase cascade.
4. Discussion
In this study, we examined the molecular mechanism of cell death
morphology alteration induced by the different concentration of BITC,
and demonstrated the involvement of the intracellular ATP level. The
complete apoptotic process involves energy requiring steps such as
caspase activation, enzymatic hydrolysis of macromolecules, chro-
matin condensation, bleb formation and apoptotic body formation. A
deﬁciency of ATP in these steps would prevent downstream
processes including caspase-3 activation, because, for example, the
failure of apoptosome formation is unable to not only activate but
572 N. Miyoshi et al. / Biochimica et Biophysica Acta 1782 (2008) 566–573also amplify the caspase cascade [35]. Also, low intracellular levels of
free ATP might permit apoptotic stimuli to induce necrosis [33,36–
40]. Consistent with the results from previous studies, the present
results showed that a greater amount of cells had their death form
shifted to necrosis in experiments using ρ cells as well as using 2DG
(Figs. 2 and 4). Hence, our results demonstrated here that higher
concentration of BITC itself rapidly reduced the intracellular ATP level
(Fig. 2A), which might block the completion of apoptosis. Also, not
only higher concentration of BITC itself [9] but also 2DG pretreatment
signiﬁcantly inhibited caspase-3 activity (Fig. 2C). Although further
study to reveal the detailed mechanism for the ATP decline by BITC is
required, we showed that both the membrane permeability enhance-
ment and inhibition of glycolytic system by BITC would partially
contribute to energy deprivation. Taken together, it appears certain
that the intracellular ATP level is a key determinant to decide the cell
death form.
In addition to the signiﬁcant role of ATP, we demonstrated that not
only apoptosis, but also necrosis were counteracted by treatment with
the caspase inhibitor, Z-VAD-fmk (Fig. 7). These results implied that
the BITC-induced necrotic-featured cell death might be a consecutive
event from the apoptosis program incompletion rather than simple
accidental death by severe physiological damage, although BITC itself
has a weak membrane lytic activity (unpublished observation). It has
recently been reported that cells triggered to undergo apoptosis are
instead forced to die by necrosis when the energy level is rapidly
compromised [36,41]. There is other evidence that in vivo, under
pathological conditions, apoptosis and necrosis may often coexist.
These imply that several types of cell death pathway can coexist in the
same cell. In contrast to apoptotic cells, which are cleared by
phagocytosis and subsequent intracellular degradation [42], necrotic
cells are thought to promote an inﬂammatory response mainly caused
by the leakage of nucleic acids prior to phagocytosis [43,44].
Therefore, reducing the necrotic cell death by regulation of the energy
level might be practical for the prevention of an undesirable
phenomenon by cytotoxic agents.
We previously demonstrated that the BITC-induced intracellular
oxidation of H2DCF-DA is mainly due to the production of hydrogen
peroxide derived from superoxide radical dismutation [9]. Our
ﬁndings were that BITC directly modiﬁes the mitochondrial respira-
tory chain [9,34] and activates ataxia telangiectasia-mutated (ATM)
possibly in response to DNA oxidative damage and ATM-dependent
p53 accumulation [24]. Previous reports indicated that ROS produced
by ITCs trigger the activation of antioxidant response element (ARE)
following to ARE-driven antioxidant enzyme induction, such as GSTP1,
GCLC, TR, and AKR1C1, through the Nrf2/Keap1 pathway [45,46].
Consistent with previous results, an ROS accumulation occurred in the
BITC-treated wild-type ρ+ HeLa cells, while the ρ° cells exhibited a
lower sensitivity (Fig. 3B). Thus the present experiment using ρ° HeLa
cells further conﬁrmed that BITC-induced ROS originated from
mitochondrial electron transfer chain with no signiﬁcant change of
various antioxidant enzyme gene expressions. We observed that the
ρ° cells are sensitive to BITC cytotoxic stimulus, even though their
apoptosis/necrosis ratio was quite distinct from that of the ρ+ cells,
indicating that the mode of cell death induced by BITC is independent
of the ROS produced, and this will depend on the reactive preference
of BITC against the energy metabolism such as glycolysis or
tricarboxylic acid cycle. It should be pointed out that, experimentally,
hydrogen peroxide failed to induce apoptosis in cells in which the ATP
levels are below roughly 25% of the control ATP levels [47,48].
Therefore, if ROS were attributable to the BITC-induced cell death, it
would also depend on the intracellular ATP level.
Future studies will examine the molecular targets and pathways
that account for the BITC-induced alteration of the ATP level in both
the ρ+ cells and ρ° cells. The rapid loss of membrane integrity in cells
treated with BITC (as evidenced by the PI uptake) indicates that the
BITC-induced necrosis derives in part from the direct attack on the cellmembrane. BITC is known to modify protein sulfhydryls [7,34,49,50]
and thus BITC may not act on membrane lipids, even though BITC-
induced ROS can oxidize them. BITC has been shown to modify and
inhibit the activities of various proteins [7,50]. As well, we observed
that GAPDH activity, having a cysteine residue at the active site, was
slightly decreased by BITC in both the ρ° and ρ+ cells (Fig. S5). The
critical task for apoptosis/necrosis switching research will be to
identify the speciﬁc molecular targets that initiate ATP deprivation.
In conclusion, to the best of our knowledge, the present study is the
ﬁrst published report to convincingly document the induction of
necrosis by an ITC class of dietary chemopreventive agents. The
present study also provides biological evidence of cell death mode
switching from apoptosis to necrosis-like cell death by BITC. The
switching was dose-dependently induced by BITC, in which the
intracellular ATP level plays a critical role in it. We preliminarily
observed that higher concentration of BITC exhibits ATP-dependent
alteration of cell death mode in several cell lines such as the renal
proximal tubular epithelial LLC-PK1 cells (Nakamura, Y. et al.,
unpublished data), suggesting that these phenomena might not be
due to cell-speciﬁc effects. The ITCs are one group of the most
promising cancer preventive agents if their amounts are relevant.
However, BITC experimentally possesses both carcinogenesis and
anti-carcinogenesis activity in a dose-dependent manner. Our results
support the idea that the intake of excess amount of ITCs, inducing
necrotic cell death, would provoke an inﬂammation reaction which
could contribute to promoting the carcinogenesis process. In this
study, we examined the concentration of BITC up to 100 μMas a supra-
pharmacological but locally achievable dose, since the recent
preclinical evaluation revealed that ITCs concentration in the gastric
luminawas temporally achieved to approximately 600–2000 μM, after
the consumption of the broccoli extract [51]. Therefore, more
attention should be paid to the dose administered as a supplement
of condensed extracts, and thus carefully designed pharmacokinetic
studies are needed before clinical testing of ITCs.
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